DMRA is Damora Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $28.00. Market cap: $1.73B.
Stock snapshot
| Price | $28.00 |
| Market cap | $1.73B |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About DMRA
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Related non-dividend companies
Other non-dividend stocks investors research alongside DMRA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is DMRA's current stock price?
DMRA (Damora Therapeutics, Inc.) is currently trading at $28.00.
Does DMRA pay a dividend?
DMRA (Damora Therapeutics, Inc.) does not currently pay a regular dividend.
Track DMRA in DiviDrip
Add DMRA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search DMRA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.